ReCept Pharmacy LP Sustainability Profile
ReCept Pharmacy LP, headquartered in the United States, is a leading player in the pharmaceutical industry, specialising in the provision of innovative medication management solutions. Founded in 2015, the company has rapidly established itself as a trusted partner for healthcare providers, particularly in the realms of specialty pharmacy and medication therapy management. With a focus on enhancing patient outcomes, ReCept Pharmacy offers a unique blend of core services, including comprehensive medication reviews and tailored patient support programmes. Their commitment to utilising advanced technology and data analytics sets them apart in a competitive market. Recognised for their exceptional service and dedication to patient care, ReCept Pharmacy has achieved significant milestones, positioning itself as a key contributor to the evolving landscape of pharmacy services across the United States.
DitchCarbon Score
How does ReCept Pharmacy LP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ReCept Pharmacy LP's score of 50 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ReCept Pharmacy LP, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Omnicell, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from ReCept Pharmacy LP, nor are there any emissions figures inherited from its parent company. While ReCept Pharmacy LP has not disclosed its own emissions data, it is important to note that the broader industry context often includes commitments to sustainability and carbon reduction. Companies in the pharmaceutical and healthcare sectors are increasingly focusing on reducing their carbon footprints, aligning with global climate initiatives. For further insights into their climate strategy, stakeholders may look to Omnicell, Inc. for any relevant emissions data or sustainability initiatives that may cascade down to ReCept Pharmacy LP.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 236,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 11,609,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - |
How Carbon Intensive is ReCept Pharmacy LP's Industry?
How Carbon Intensive is ReCept Pharmacy LP's Location?
ReCept Pharmacy LP's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ReCept Pharmacy LP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
